Dr. Rahul Bhargava

Dr. Rahul Bhargava is a pioneering figure in the field of hematology and stem cell transplant in India. He began his stem cell transplant journey at Medanta in 2010 and has since successfully completed over 800 transplants. His dedication to making treatment accessible led him to establish 10 low-cost bone marrow transplant centers across India, including at Sarvodaya Hospital, Batra Hospital, and Action Balaji Hospital. Driven by a vision for a Thalassemia- and Anemia-free India, Dr. Bhargava actively collaborates with government programs to deliver affordable transplant care to underserved communities. His dream of creating an integrated center of excellence in hematology, pediatric hematology, and stem cell transplant was realized at Fortis Memorial Research Institute.

In 2016, he became the first Indian doctor to introduce and promote stem cell transplant for treating multiple sclerosis. Dr. Bhargava is widely regarded as one of the leading stem cell transplant and hematology experts in Delhi and Gurgaon. His passion for community health is evident from his initiatives, including screening over 500 school children in Haryana in 2018 and conducting more than 1000 CMEs to date.

Research:

• Published extensively on PubMed (Search: Rahul Bhargava)

• MBBS
• MD (Medicine)
• DM (Clinical Haematology)

• Leukemia (AML, ALL, CML, CLL)
• Lymphoma (Hodgkin’s & Non-Hodgkin’s)
• Multiple Myeloma
• Thalassemia
• Aplastic Anemia
• Sickle Cell Disease
• Myelodysplastic Syndromes (MDS)
• Primary Immunodeficiencies
• Autoimmune Disorders (e.g., Multiple Sclerosis)
• Bone Marrow Failure Syndromes
• Childhood Leukemia Congenital Blood Disorders

• Aplastic Anemia Treatment
• Bone Marrow Transplant
• Leukemia Treatment
• Multiple Myeloma Treatment
• Polycythemia Vera Treatment
• Sickle Cell Anemia Treatment
• Thalassemia Treatment
• Autologous Stem Cell Transplant
• Allogeneic Stem Cell Transplant
• Cord Blood Transplant
• Stem Cell Transplant for Multiple Sclerosis (First in India to popularize this)
• Blood Cancers Treatment (ALL, AML, JMML, CML) & Lymphoma (Hodgkin & Non-Hodgkin)
• Neuroblastoma Treatment
• Germ Cell Tumor (GCT) Treatment
• Bone and Soft Tissue (Sarcoma) Treatment
• Langerhans Cell Histiocytosis (LCH) and Rare Childhood Cancer Treatment
• Thalassemia and Sickle Cell Disease Treatment
• Hematopathology and Molecular Hematology
• Matched sibling, unrelated, and haploidentical transplants

• Founding Member, Delhi Hematology Group
• Member, ISHTM Visiting Faculty at national and international universities
• Active developer of hematology programs in Uzbekistan, Iraq, Uganda, Rwanda, and more
• Campaign leader: “Say No to Whole Blood” – promoting blood component awareness
• Champion of Community Hematology and the Anaemia Free India mission

• MedAchievers Healthcare Icon Award (for his contribution to hematology)
• The Excellence in Hematology and Stem Cell Transplant Award from the Union Health Minister
• The Best Doctor Award by Six Sigma Star Healthcare